Cargando…

Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression

Sepsis is a leading cause of death in intensive care units and survivors develop prolonged immunosuppression and a high incidence of recurrent infections. No definitive therapy exists to treat sepsis and physicians rely on supportive care including antibiotics, intravenous fluids, and vasopressors....

Descripción completa

Detalles Bibliográficos
Autores principales:	McBride, Margaret A., Patil, Tazeen K., Bohannon, Julia K., Hernandez, Antonio, Sherwood, Edward R., Patil, Naeem K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886986/ https://www.ncbi.nlm.nih.gov/pubmed/33613563 http://dx.doi.org/10.3389/fimmu.2020.624272

Ejemplares similares

The Metabolic Basis of Immune Dysfunction Following Sepsis and Trauma
por: McBride, Margaret A., et al.
Publicado: (2020)

MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages
por: Owen, Allison M., et al.
Publicado: (2022)

Targeting Immune Cell Checkpoints during Sepsis
por: Patil, Naeem K., et al.
Publicado: (2017)

Editorial: The Roles of Mitochondria in Immunity
por: Patil, Naeem K., et al.
Publicado: (2022)

TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection
por: Owen, Allison M., et al.
Publicado: (2021)

IL-15 Superagonist Expands mCD8(+ )T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound Infection
por: Patil, Naeem K., et al.
Publicado: (2016)

Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression
por: Yao, Ren-Qi, et al.
Publicado: (2022)

Autophagy: A Potential Therapeutic Target for Reversing Sepsis-Induced Immunosuppression
por: Ren, Chao, et al.
Publicado: (2017)

Park 7: A Novel Therapeutic Target for Macrophages in Sepsis-Induced Immunosuppression
por: Cheng, Yanwei, et al.
Publicado: (2018)

Epigenetics in Sepsis: Understanding Its Role in Endothelial Dysfunction, Immunosuppression, and Potential Therapeutics
por: Cross, Deborah, et al.
Publicado: (2019)

Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review
por: Eskandari-Malayeri, Fatemeh, et al.
Publicado: (2022)

Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients
por: Petrova, Vera, et al.
Publicado: (2023)

Comprehensive immune profiling reveals that Orbivirus infection activates immune checkpoints during acute T cell immunosuppression
por: Louloudes-Lázaro, Andrés, et al.
Publicado: (2023)

The Neonatal Innate Immune Response to Sepsis: Checkpoint Proteins as Novel Mediators of This Response and as Possible Therapeutic/Diagnostic Levers
por: Hensler, Emily, et al.
Publicado: (2022)

Immune Checkpoints as Therapeutic Targets in Autoimmunity
por: Paluch, Christopher, et al.
Publicado: (2018)

The role of natural killer cells in the pathogenesis of sepsis: the ongoing enigma
por: Bohannon, Julia, et al.
Publicado: (2012)

Trained Immunity Enhances Human Monocyte Function in Aging and Sepsis
por: Gill, P. Spencer, et al.
Publicado: (2022)

CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors
por: Chen, Yu, et al.
Publicado: (2020)

Case Report: A severe case of immunosuppressant-refractory immune checkpoint inhibitor-mediated colitis rescued by tofacitinib
por: Sweep, Mark W. D., et al.
Publicado: (2023)

Comparative Transcriptome Profiles of Human Blood in Response to the Toll-like Receptor 4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A
por: Luan, Liming, et al.
Publicado: (2017)

BTLA as a biomarker and mediator of sepsis-induced immunosuppression
por: Sherwood, Edward R, et al.
Publicado: (2013)

Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade
por: Zheng, Weiwei, et al.
Publicado: (2022)

Of mice and men: Laboratory murine models for recapitulating the immunosuppression of human sepsis
por: Wang, Ning, et al.
Publicado: (2022)

Negative Immune Checkpoint Protein, VISTA, Regulates the CD4(+) T(reg) Population During Sepsis Progression to Promote Acute Sepsis Recovery and Survival
por: Gray, Chyna C., et al.
Publicado: (2022)

Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade
por: Mougel, Alice, et al.
Publicado: (2019)

Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases
por: Zhai, Yujia, et al.
Publicado: (2021)

Novel Immune Checkpoints in Esophageal Cancer: From Biomarkers to Therapeutic Targets
por: Zhou, Xueyin, et al.
Publicado: (2022)

The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancer
por: Zohair, Basma, et al.
Publicado: (2023)

Contribution of Dendritic Cell Responses to Sepsis-Induced Immunosuppression and to Susceptibility to Secondary Pneumonia
por: Bouras, Marwan, et al.
Publicado: (2018)

Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
por: Genova, Carlo, et al.
Publicado: (2022)

Critical roles of sepsis-reshaped fecal virota in attenuating sepsis severity
por: Chancharoenthana, Wiwat, et al.
Publicado: (2022)

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
por: Zemek, Rachael M., et al.
Publicado: (2020)

PD-1 blockade attenuates surgery-mediated immunosuppression and boosts Th1 immunity perioperatively in oesophagogastric junctional adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2023)

External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition
por: Glehr, Gunther, et al.
Publicado: (2022)

Influence of Tumor Immune Infiltration on Immune Checkpoint Inhibitor Therapeutic Efficacy: A Computational Retrospective Study
por: Liu, Rong, et al.
Publicado: (2021)

Regulatory role of the programmed cell death 1 signaling pathway in sepsis induced immunosuppression
por: Zhong, Shubai, et al.
Publicado: (2023)

Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation
por: Dumolard, Lucile, et al.
Publicado: (2023)

NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma
por: Miftah, Hayat, et al.
Publicado: (2023)

Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies
por: Huang, Boyuan, et al.
Publicado: (2023)

Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
por: Wang, Xiaoqiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rvplfljdbpd8iqfv05t8s8a6n6